A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: A phase II double-blind, randomized placebo-controlled study

Category Primary study
JournalCLINICAL AND INVESTIGATIVE MEDICINE
Year 2012
This article has no abstract
Epistemonikos ID: 89186dd5d63dd901f4296e81866315c3f3a7dd08
First added on: Nov 17, 2025